Inhibitory effect of schizandrin on passive cutaneous anaphylaxis reaction and scratching behaviors in mice

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 6, 2007, Pages 1153-1156

  Lee, Bomi ^a   Bae, Eun Ah ^a   Trinh, Hien Trung ^a   Shin, Yong Wook ^a   Phuong, Thien Thuong ^b   Bae, Ki Hwan ^b   Kim, Dong Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Chungnam National University   (South Korea)

Author keywords

Allergy; Anaphylaxis; IgE; Schizandrin

Indexed keywords

ANTIALLERGIC AGENT; ANTIGEN; AZELASTINE; BETAMETHASONE; COMPOUND 48-80; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 4; OVALBUMIN; SCHIZANDRIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; FRUIT; IMMUNOMODULATION; IMMUNOPHARMACOLOGY; IN VITRO STUDY; INHIBITION KINETICS; MALE; MOUSE; NONHUMAN; PERITONEUM MAST CELL; PROTEIN EXPRESSION; RAT; SCHISANDRACEAE; SCHIZANDRA CHINENSIS; SCRATCHING; SKIN ANAPHYLAXIS;

ANIMALS; ANTI-ALLERGIC AGENTS; CYCLOOCTANES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; INTERLEUKIN-4; LIGNANS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED ICR; MOLECULAR STRUCTURE; P-METHOXY-N-METHYLPHENETHYLAMINE; PASSIVE CUTANEOUS ANAPHYLAXIS; PLANT EXTRACTS; POLYCYCLIC COMPOUNDS; PRURITUS; SCHISANDRA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34250024103     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.1153     Document Type: Article

References (25)

1. Stevens R. L., Austen K. F., Immunol. Today, 10, 381-386 (1989).
2. Plaut M., Pierce J. H., Whatson C., Hanley-Hyde J., Nordan R. P., Paul W. E., Nature (London), 339, 64-67 (1989).
3. Bruhns P., Fremont S., Daeron M., Curr. Opin. Immunol., 17, 662-669 (2005).
4. Nicoloff B., J. Arch. Dermatol., 127, 871-884 (1991).
5. Mitre E., Nutman T. B., Chem. Immunol. Allergy, 90, 141-156 (2006).
6. Wuthrich B., Int. Arch. Allergy Appl. Immunol., 90(Suppl. 1), 3-10 (1989).
7. Schafer-Korting M., Schmid M. H., Korting H. C., Drug Safety, 14, 375-385 (1996).
8. Sakuma S., Higashi Y., Sato N., Sasakawa T., Sengoku T., Ohkubo Y., Amaya T., Goto T., Int. Immunopharmacol., 1, 1219-1226 (2001).
9. Simons F. E., J. Allergy Clin. Immunol., 90, 705-715 (1992).
10. Bielory L., Ann. Allergy Asthma Immunol., 93(Suppl. 1), S45-S54 (2004).
11. Yang S. H., Hong C. Y., Yu C. L., Int. Immunopharmacol., 1, 1173-1182 (2001).
12. Ram V. J., Drug News Perspect., 14, 353-363 (2001).
13. Ohkura Y., Mizoguchi Y., Morisawa S., Takeda S., Aburada M., Hosoya E., Jpn J. Pharmacol., 52, 331-336 (1990).
14. Wang J. P., Raung S. L., Hsu M. F., Chen C. C., Br. J. Pharmacol., 113, 945-953 (1994).
15. Yasukawa K., Ikeya Y., Mitsuhashi H., Iwasaki M., Aburada M., Nakagawa S., Takeuchi M., Takido M., Oncology, 49, 68-71 (1992).
16. Ikeya Y., Taguchi H., Yosioka I., Kobayashi H., Chem. Pharm. Bull., 27, 1383-1394 (1979).
17. Lee I. S., Jung K. Y., Oh S. R., Park S. H., Ahn K.S., Lee H. K., Biol. Pharm. Bull., 22, 265-267 (1999).
18. Choo M. K., Park E. K., Han M. J., Kim D. H., Planta Med., 69, 518-522 (2003).
19. Sugimoto Y., Umakoshi K., Nojiri N., Kamei C., Eur. J. Pharmacol., 351, 1-5 (1998).
20. Chen C. L., Wang S. D., Zeng Z. Y., Lin K. J., Kao S. T., Tani T., Yu C. K., Wang J. Y., J. Allergy Clin. Immunol., 118, 105-112 (2006).
21. Mastuda H., Morikawa T., Ueda K., Managi H., Yoshikawa M., Bioorg. Med. Chem., 10, 2123-3128 (2002).
22. Akagi M., Mio M., Miyoshi K., Tasaka K., Immunopharmacol. Immunotoxicol., 9, 257-7924 (1987).
23. Ito H., Miyazaki T., Ono M., Sakurai H., Bioorg. Med. Chem., 6, 1051-1056 (1998).
24. Xu M., Wang G., Xie H., Wang R., Wang W., Li X., Li H., Zhu D., Yue L., J. Chromatogr. B, Analyt. Technol. Biomed. Life Sci., 828, 55-61 (2005).
25. Lee I. S., Lee H. K., Dat N. T., Lee M. S., Kim J. W., Na D. S., Kim Y. H., Planta Med., 69, 63-64 (2003).